纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | FDMT | 4D Molecular Therapeutics Inc | 39.25 | 0.03% |
| 2024-12-31 | CCCC | C4 Therapeutics Inc | 38.73 | 0.03% |
| 2024-12-31 | DSGN | Design Therapeutics Inc | 53.25 | 0.03% |
| 2024-12-31 | FHTX | Foghorn Therapeutics Inc | 40 | 0.03% |
| 2024-12-31 | NKTX | Nkarta Inc | 26.78 | 0.02% |
| 2024-12-31 | MRSN | 梅莎娜制药 | 26.93 | 0.02% |
| 2024-12-31 | ARTV | Artiva Biotherapeutics Inc | 37.32 | 0.02% |
| 2024-12-31 | LXEO | Lexeo Therapeutics Inc | 33.16 | 0.02% |
| 2024-12-31 | ACRV | Acrivon Therapeutics Inc | 28.57 | 0.02% |
| 2024-12-31 | ALEC | Alector Inc | 28.21 | 0.02% |
| 2024-12-31 | FATE | Fate Therapeutics Inc | 28.64 | 0.02% |
| 2024-12-31 | MGNX | MacroGenics Inc | 31.09 | 0.02% |
| 2024-12-31 | SCPH | scPharmaceuticals Inc | 27 | 0.02% |
| 2024-12-31 | IGMS | IGM Biosciences Inc | 31.74 | 0.02% |
| 2024-12-31 | CMPS | COMPASS Pathways plc ADR | 29.3 | 0.02% |
| 2024-12-31 | AMRN | 阿玛琳 | 29.59 | 0.02% |
| 2024-12-31 | TVGN | Tevogen Bio Holdings Inc | 27.48 | 0.02% |
| 2024-12-31 | KYTX | Kyverna Therapeutics Inc | 24.61 | 0.02% |
| 2024-12-31 | INBX | Inhibrx Biosciences Inc | 33.97 | 0.02% |
| 2024-12-31 | LRMR | Larimar Therapeutics Inc | 37.64 | 0.02% |
公告&资料
